Day: December 13, 2022

KELOWNA, British Columbia, Dec. 13, 2022 (GLOBE NEWSWIRE) — Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, today reported on corporate highlights from 2022 and announced the filing of its audited financial statements for the fiscal year ending August 31, 2022. Complete financial statements along with related management discussion and analysis can be found in the System for Electronic Document Analysis and Retrieval, the electronic filing system for the disclosure documents of issuers across Canada, at www.SEDAR.com. CORPORATE HIGHLIGHTS Intellectual Property DevelopmentsTryp made significant progress expanding its IP portfolio, including:The World Intellectual...

Sales totaled $16.2 million Net loss of $4.7 million Adjusted EBITDA amounted to negative $2.0 million Cash position of $16.1 millionMONTREAL, Dec. 13, 2022 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today its third quarter results for the period ended October 29, 2022. “We remain focused on our competitive advantages with a strategic retail presence across Canada, a strong wellness-driven portfolio of teas, innovative product launches and broad demographic appeal of our brand both online and in-store. We anticipate our financial results will be under pressure until the economic environment becomes more stable. At this time, it’s not possible to forecast the extent and duration of the difficult market conditions, but we can lean on our omnichannel...

Posted fourth quarter revenue of $2.0 billion, up 19% year-over-year, with 6% organic growth Delivered fourth quarter net income of $48.9 million and GAAP EPS of $0.73, a year-over-year increase of 43% and 46%, respectively Generated fourth quarter adjusted EBITDA of $130.7 million, up 18% year-over-year Recorded fourth quarter adjusted EPS of $0.89, up 5% year-over-year Received Board approval for a $150 million expansion of the Company’s existing share repurchase authorizationNEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for the fourth quarter and full year ended October 31, 2022. “ABM generated solid fourth quarter results, with total revenue growth of 19%, including broad-based organic revenue growth of 6%, and double-digit adjusted...

FORT MYERS, Fla., Dec. 13, 2022 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announces financial results for the fourth quarter and fiscal year ended September 30, 2022, the highlights of which are as follows:Company reports net income attributable to Alico, Inc. common stockholders of $12.5 million and EBITDA of $32.1 million for the fiscal year 2022. After adjusting for certain non-recurring items, Company reports adjusted net loss attributable to Alico, Inc. common stockholders of $1.6 million and Adjusted EBITDA of $13.4 million.Company’s fiscal year 2022 financial results are below the most recent net income and EBITDA guidance, primarily due to the approximately $23.0 million of inventory and casualty losses incurred as a result of the impact of Hurricane Ian; however, adjusting out for...

Restructuring plan increases year-over-year gross margin to 60% from 51%, and narrows net loss to $(2.3) million from $(2.9) million Adjusted EBITDA of $0.5 million versus $(0.7) million in prior year quarter Positive operating cash flow of $1.0 million versus $(1.0) million in prior year quarterNEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) — Aspen Group, Inc. (Nasdaq: ASPU) (“AGI” or the “Company”), an education technology holding company, today announced financial results for its second quarter fiscal year 2023 ended October 31, 2022. Second Quarter Fiscal Year 2023 Summary Results  Three Months Ended October 31,   Six Months Ended October 31,  2022   2021   2022   2021$ in millions, except per share data            Revenue $ 17.1       $ 18.9       $ 36.0       $ 38.4    Gross Profit1 $ 10.2       $ 9.7       $ 18.4       $ 20.1    Gross...